NO984739L - Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer - Google Patents
Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorerInfo
- Publication number
- NO984739L NO984739L NO984739A NO984739A NO984739L NO 984739 L NO984739 L NO 984739L NO 984739 A NO984739 A NO 984739A NO 984739 A NO984739 A NO 984739A NO 984739 L NO984739 L NO 984739L
- Authority
- NO
- Norway
- Prior art keywords
- cyclopent
- piperidines
- indole
- spiro
- preparation
- Prior art date
Links
- LMKPHJYTFHAGHK-UHFFFAOYSA-N cyclodrine Chemical compound C1CCCC1(O)C(C(=O)OCCN(CC)CC)C1=CC=CC=C1 LMKPHJYTFHAGHK-UHFFFAOYSA-N 0.000 title abstract 3
- 239000000543 intermediate Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 125000003003 spiro group Chemical group 0.000 title abstract 3
- XVTILWLVPDMCSO-UHFFFAOYSA-N 1h-indole;piperidine Chemical class C1CCNCC1.C1=CC=C2NC=CC2=C1 XVTILWLVPDMCSO-UHFFFAOYSA-N 0.000 title 1
- 102000012440 Acetylcholinesterase Human genes 0.000 title 1
- 108010022752 Acetylcholinesterase Proteins 0.000 title 1
- 229940022698 acetylcholinesterase Drugs 0.000 title 1
- 229940082992 antihypertensives mao inhibitors Drugs 0.000 title 1
- 239000000544 cholinesterase inhibitor Substances 0.000 title 1
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 208000020401 Depressive disease Diseases 0.000 abstract 1
- 150000007857 hydrazones Chemical class 0.000 abstract 1
- 230000007074 memory dysfunction Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63064196A | 1996-04-10 | 1996-04-10 | |
| PCT/US1997/003864 WO1997037992A2 (en) | 1996-04-10 | 1997-03-10 | Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO984739D0 NO984739D0 (no) | 1998-10-09 |
| NO984739L true NO984739L (no) | 1998-12-09 |
Family
ID=24527997
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO984739A NO984739L (no) | 1996-04-10 | 1998-10-09 | Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0892802B1 (de) |
| JP (1) | JP3615225B2 (de) |
| KR (1) | KR100270145B1 (de) |
| CN (1) | CN1233249A (de) |
| AR (1) | AR006553A1 (de) |
| AT (1) | ATE252581T1 (de) |
| AU (1) | AU708124B2 (de) |
| BR (1) | BR9708563A (de) |
| CA (1) | CA2251545C (de) |
| DE (1) | DE69725713T2 (de) |
| DK (1) | DK0892802T3 (de) |
| ES (1) | ES2207718T3 (de) |
| HU (1) | HUP9902755A3 (de) |
| IL (1) | IL126003A0 (de) |
| NO (1) | NO984739L (de) |
| PT (1) | PT892802E (de) |
| WO (1) | WO1997037992A2 (de) |
| ZA (1) | ZA972984B (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000018391A1 (en) | 1998-09-30 | 2000-04-06 | Takeda Chemical Industries, Ltd. | Drugs for improving vesical excretory strength |
| CA2788656A1 (en) | 2010-02-16 | 2011-08-25 | Pfizer Inc. | (r)-4-((4-((4-(tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2h-pyran-4-ol, a partial agonist of 5-ht4 receptors |
| EP3340988B1 (de) | 2015-11-12 | 2025-04-09 | Afasci, Inc. | Ionenkanalhemmende verbindungen, pharmazeutische formulierungen und verwendungen |
| WO2020048827A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 1, 3, 9-triazaspiro[5.5] undecan-2-one compounds |
| WO2020048829A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Aktiengesellschaft | 3,9-diazaspiro[5.5]undecane compounds |
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
-
1997
- 1997-03-01 IL IL12600397A patent/IL126003A0/xx unknown
- 1997-03-10 AU AU19909/97A patent/AU708124B2/en not_active Ceased
- 1997-03-10 AT AT97908068T patent/ATE252581T1/de not_active IP Right Cessation
- 1997-03-10 DK DK97908068T patent/DK0892802T3/da active
- 1997-03-10 CA CA002251545A patent/CA2251545C/en not_active Expired - Fee Related
- 1997-03-10 JP JP53619797A patent/JP3615225B2/ja not_active Expired - Fee Related
- 1997-03-10 KR KR1019980708047A patent/KR100270145B1/ko not_active Expired - Fee Related
- 1997-03-10 EP EP97908068A patent/EP0892802B1/de not_active Expired - Lifetime
- 1997-03-10 CN CN97193690A patent/CN1233249A/zh active Pending
- 1997-03-10 WO PCT/US1997/003864 patent/WO1997037992A2/en not_active Ceased
- 1997-03-10 BR BR9708563A patent/BR9708563A/pt not_active IP Right Cessation
- 1997-03-10 DE DE69725713T patent/DE69725713T2/de not_active Expired - Fee Related
- 1997-03-10 HU HU9902755A patent/HUP9902755A3/hu unknown
- 1997-03-10 PT PT97908068T patent/PT892802E/pt unknown
- 1997-03-10 ES ES97908068T patent/ES2207718T3/es not_active Expired - Lifetime
- 1997-04-08 ZA ZA9702984A patent/ZA972984B/xx unknown
- 1997-04-08 AR ARP970101376A patent/AR006553A1/es not_active Application Discontinuation
-
1998
- 1998-10-09 NO NO984739A patent/NO984739L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002509520A (ja) | 2002-03-26 |
| KR20000005328A (ko) | 2000-01-25 |
| AR006553A1 (es) | 1999-09-08 |
| CA2251545A1 (en) | 1997-10-16 |
| ATE252581T1 (de) | 2003-11-15 |
| EP0892802B1 (de) | 2003-10-22 |
| IL126003A0 (en) | 1999-04-11 |
| HUP9902755A2 (hu) | 2000-03-28 |
| JP3615225B2 (ja) | 2005-02-02 |
| DE69725713D1 (de) | 2003-11-27 |
| AU1990997A (en) | 1997-10-29 |
| EP0892802A1 (de) | 1999-01-27 |
| ES2207718T3 (es) | 2004-06-01 |
| KR100270145B1 (ko) | 2000-11-01 |
| CA2251545C (en) | 2002-01-08 |
| HUP9902755A3 (en) | 2000-05-29 |
| DE69725713T2 (de) | 2004-05-13 |
| WO1997037992A2 (en) | 1997-10-16 |
| NO984739D0 (no) | 1998-10-09 |
| ZA972984B (en) | 1997-11-03 |
| PT892802E (pt) | 2004-03-31 |
| BR9708563A (pt) | 1999-08-03 |
| CN1233249A (zh) | 1999-10-27 |
| AU708124B2 (en) | 1999-07-29 |
| DK0892802T3 (da) | 2003-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20091761L (no) | Viruskapsomervaksine, fremgangsmate for fremstilling samt anvendelse derav | |
| MY131298A (en) | 5-heteroyl indole derivatives | |
| IL128003A0 (en) | Therapeutic multispecific compounds comprised of anti-fcalpha receptor antibodies | |
| DK1076657T3 (da) | Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling | |
| EP0987263A3 (de) | Aryliden und Heteroaryliden-oxindolderivate als Tyrosin Kinase Inhibitoren | |
| NO963731L (no) | Behandling av obsessive-kompulsive sykdommer med 5HT2-antagonister | |
| NO973607D0 (no) | Nye farnesyltransferaseinhibitorer, deres fremstilling og preparater inneholdende inhibitorene | |
| NO972910L (no) | Tetracykliske spiroforbindelser, fremgangsmåte for fremstilling og anvendelse derav som 5HT1D reseptor-antagonister | |
| NO20021541L (no) | 5-beta-sapogenin- og pseudosapogeninderivater samt deres anvendelse ved behandling av demens | |
| NO985574L (no) | FremgangsmÕter og preparater anvendelige for inhibering av angiogenese | |
| FI956074A0 (fi) | Asetyylikolinesteraasin inhibiittoreina toimivia 1-asemasta substituoituja isatiini- ja oksindolijohdannaisia | |
| AU3508497A (en) | Androgen receptor modulator compounds and methods | |
| NO986089L (no) | Metoder og preparater for behandling av tumorer, tumorrelaterte sykdommer og kakeksi | |
| YU59098A (sh) | Derivati spiro-piperidina, postupak njihovog dobijanja, njihova upotreba u proizvodnji leka korisnog za lečenje ili prevenciju bolova, upalnih procesa, migrene, povraćanja i postherpetične neuralgije i farmaceutski sastav koji ih sadrži | |
| NO20073113L (no) | Indenylderivater og anvendelse derav for behandling av neurologiske lidelser | |
| NO975711L (no) | Nye Dolastatinderivater, deres fremstilling og anvendelse | |
| NO990433L (no) | Nye forbindelser og blandinger for behandling av sykdommer i forbindelse med tryptase-aktivitet | |
| NZ333441A (en) | Use of k-252a derivatives for the treatment of peripheral or central nerve disorders, and cytokine overproduction | |
| EP1435945A4 (de) | Transdermale migränetherapie | |
| NO963850D0 (no) | Heterosykliske forbindelser, deres fremstilling og anvendelse | |
| NO984739L (no) | Spiro[cyklopent[b]indolpiperidiner og N-fenyl-hydrazon-mellomprodukter for deres fremstilling, hvor begge er acetylcholinesterase og MAO-inhibitorer | |
| NO985671D0 (no) | Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem | |
| TR199700956T1 (xx) | Indazolkarboksamidler. | |
| NO984624D0 (no) | Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav | |
| ZA974688B (en) | Oxime derivatives of indoles and indenes as inhibitors of prostaglandin biosynthesis. |